A new hope for patients with Huntington's disease? [PDF]
eClinicalMedicine.
europepmc +1 more source
The Molecular Architecture of Neurodegeneration: An Integrative Overview of Convergent Mechanisms. [PDF]
Aranda-Abreu GE +5 more
europepmc +1 more source
Polyglutamine Flanking Regions in Huntingtin Highlight Key Structural Intermediates Relevant for Molecular Chaperone Interaction and Huntington's Disease Pathogenesis [PDF]
Koning Shen +3 more
openalex +1 more source
Proteasomal Degradation of Mutant Huntingtin Exon1 Regulates Autophagy. [PDF]
Folger A +4 more
europepmc +1 more source
Regulation of nuclear transport of the transcriptional factor REST improves axon regeneration in peripheral nerves. [PDF]
Suzuki T +10 more
europepmc +1 more source
A046 Uncovering the pathobiology of polyglutamine-expanded huntingtin in Huntington’s disease [PDF]
Erich E. Wanker
openalex +1 more source
La maladie de Huntington (MH) est une maladie neurodégénérative héréditaire autosomique dominante. Elle résulte d’une expansion anormale de glutamines (polyQ) dans la partie N-terminale de la protéine huntingtine (HTT ; codé par HTT). La MH est caractérisée par la dysfonction et la mort de cellules neuronales dans le cerveau, entraînant l’apparition de
openaire +1 more source
Brain-Derived Neurotrophic Factor Trafficking via the Regulated Secretory Pathway: Mechanisms and Disease Implications. [PDF]
Ewell SN.
europepmc +1 more source
Fibrilpaints as a tool to bind and modulate huntingtin amyloids
Françoise A. Dekker +4 more
openalex +1 more source

